Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1346

Oct 25, 2020

The Elysium effect: The coming backlash to the billionaire ‘NewSpace’ revolution

Posted by in categories: biotech/medical, Elon Musk, space

In the 2013 science fiction film “Elysium” starring Matt Damon, Earth’s wealthiest 0.01% move to the ultimate gated community, a luxurious orbiting space colony, leaving a poverty-stricken humanity to fend for themselves on a ravaged planet.

Interestingly, it is indeed some of today’s 0.1% who are leading the way into space to build communities beyond Earth. However, quite the opposite of the movie, their goals are of the highest order, from democratizing access to space by lowering costs, to creating new products and ideas, to helping save the planet and opening space to future generations.

Yet, given the effects of the coronavirus pandemic, social justice and green movements, even as entrepreneurs like Elon Musk, Jeff Bezos and Richard Branson spend billions to support a human breakout into space, there is a backlash building that holds these projects as icons of extravagance — even as their work may help save the Earth. This is the “Elysium effect.”

Oct 24, 2020

Drug-resistant superbug thriving in hospitals hit hard by COVID-19

Posted by in category: biotech/medical

Such superbugs may also be contributing to the tens of thousands of excess deaths occurring during the COVID-19 era. Hence why doctors around the world are sounding the alarm.


Doctors worry that a dangerous yeast, which can colonize a person’s skin without generating symptoms, is rising due to medical centers being overrun.

Oct 24, 2020

New CRISPR-Based Imaging Tool Is Going to Be HiUGE

Posted by in categories: bioengineering, biotech/medical, genetics

A team of researchers at Duke University have developed an imaging technology for tagging structures at a cellular level that overcomes the shortcomings of existing antibody-based techniques. Immunofluorescence imaging is a key part of the cell biologist’s toolbox, in which a fluorescent ‘flare’ attached to an antibody allows them to visualize the presence of specific target proteins in cell or tissue samples. The issue is that this specificity isn’t always 100 percent — sometimes the antibodies bind to other closely related proteins as well, making it difficult to interpret the results.

Duke’s cell biology chair Scott Soderling has led a team that developed Homology-independent Universal Genome Engineering (HiUGE), an innovation that uses gene-editing technology to rise above the shortcomings of traditional commercial antibodies for imaging.

Continue reading “New CRISPR-Based Imaging Tool Is Going to Be HiUGE” »

Oct 24, 2020

Florida could see a sea turtle baby boom—thanks to pandemic

Posted by in category: biotech/medical

Good news for the sea turtles! 😃


Tourism is down, but nesting success may be up. Here’s what scientists are saying and how travelers can help.

Oct 24, 2020

Happiness and the Evolution of Brain Size

Posted by in categories: biotech/medical, evolution, genetics, neuroscience

Summary: Study reveals a new role for serotonin in the development of the human neocortex. Serotonin acts cell-extrinsically as a growth factor for basal progenitors in the developing neocortex. Researchers report placenta-driven serotonin likely contributed to the evolutionary expansion of the neocortex in humans.

Source: Max Planck Society

During human evolution, the size of the brain increased, especially in a particular part called the neocortex. The neocortex enables us to speak, dream and think. In search of the causes underlying neocortex expansion, researchers at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, together with colleagues at the University Hospital Carl Gustav Carus Dresden, previously identified a number of molecular players. These players typically act cell-intrinsically in the so-called basal progenitors, the stem cells in the developing neocortex with a pivotal role in its expansion.

Oct 24, 2020

New Metastatic Breast Cancer Treatments and Breakthroughs of 2019

Posted by in categories: biotech/medical, innovation

#BreastCancerAwarenessMonth
Breast cancer treatments are always evolving and improving. In 2019, fresh perspectives to approach cancer therapy led to exciting breakthroughs for treatments in research.

Today’s treatments are more targeted and capable of altering the breast cancer disease course while also maintaining your quality of life. In recent years, many therapeutic options have emerged for treating stage 4, or metastatic breast cancer, greatly improving survival rates.


Breast cancer treatment research is ongoing and always improving the lives of those living with the condition. Here are the breakthrough treatments of 2019 as well as current treatments and information on finding a cure.

Oct 24, 2020

Tesla Model Y May Soon Get ‘Bioweapon Defense Mode’ with HEPA Filter

Posted by in categories: biotech/medical, military

Well, considering current events…


The Tesla HEPA Filter and Bioweapon Defense Mode have repeatedly proven their usefulness and even vital necessity. At the moment, only Model S and Model X have the air-cleaning feature, however, there is a high probability that the HEPA filter will be installed in Model Y.

Hacker @greentheonly/Twitter has once again noticed several updates that should be made available to Model Y. He claims that the car will receive a HEPA filter and the corresponding Bioweapon Defense Mode. He also clarified that Model 3 most likely won’t receive it at this point.

Continue reading “Tesla Model Y May Soon Get ‘Bioweapon Defense Mode’ with HEPA Filter” »

Oct 24, 2020

CRISPR turns normal body fat into a type that burns energy

Posted by in categories: bioengineering, biotech/medical

Animal studies suggest the metabolic conditions linked to obesity could be treated by using CRISPR gene editing to turn normal fat into heat-producing beige fat.

Oct 24, 2020

New imaging method reveals HIV’s sugary shield in unprecedented detail

Posted by in categories: biotech/medical, mapping

Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules that help shield HIV from the immune system.

Mapping these shields will give researchers a more complete understanding of why antibodies react to some spots on the virus but not others, and may shape the design of new vaccines that target the most vulnerable and accessible sites on HIV and other viruses.

The sugar molecules, or “glycans,” are loose and stringy, and function as shields because they are difficult for antibodies to grip and block access to the . The shields form on the outermost spike proteins of HIV and many other viruses, including SARS-CoV-2, the coronavirus that causes COVID-19, because these viruses have evolved sites on their spike proteins where glycan molecules—normally abundant in cells—will automatically attach.

Oct 24, 2020

Oxford coronavirus vaccine provides ‘strong’ immune response, analysis finds

Posted by in category: biotech/medical

‘This is only good news in our fight against the illness,’ researcher says.